Thank you, Ray. Slide 13 please. When I look back on our outstanding first half results following a record 2020, I see a team that is executing at a high level and a strategy that is delivering according to our plan. We have been constantly refreshing our portfolio, divesting from non-strategic businesses and redeploying capital consistent with our strategy. In doing so, we've built industry-leading capabilities to meet customer and consumer needs in high-growth categories such as meat alternatives, a category we expect to reach more than $100 billion in sales worldwide by 2030 and in which our PlantPlus Foods joint venture, now is participating, selling consumer products across Brazil and ready in its North American launch. Another example is dietary supplements, a segment on track to have $80 billion in sales globally by 2025; and in which we're constantly expanding our product portfolio including our recently introduced Bio-Kult Brighten, which includes ingredients to reduce tiredness and fatigue. And then there is pet food, which is forecast to grow to more than $130 billion globally by 2025 and an area in which we launched our new premium cat food in Mexico, earlier this year. The list goes on. Renewable green diesel, pharmaceuticals and personal care, beverages all large high-growth opportunities powered by macro consumer trends like sustainability and health and wellbeing. And in each of those segments and more, our unparalleled global footprint, fully integrated value chain, customer insight, broad portfolio and speed to market are setting us ahead of the competition and fueling our growth. That's why, we are so optimistic about our path forward. Of course, there are always going to be short-term factors for us to navigate. But those are not things that will impact our long-term success. Our confidence is rooted in the transformation we began a decade ago and which continues with our work in productivity and innovation, as well as our expanding participation in large and fast-growing market opportunities. So to conclude, we have a great start of the year and we expect to continue our momentum, in the second half to deliver very strong 2021 earnings. As we've discussed, we are moving to a new phase of our strategic growth plan. With what we have accomplished over the years on capital discipline targeted cost reductions and cash generation and moving through our portfolio transformation and our efforts to optimize business performance, drive efficiencies and expand strategically. I believe, we have successfully increased our base earnings power from $3 a share back in 2015 to a range of $4 to $4.50 this year. And now, as we enter the next stage of our growth leveraging the key macro trends of food security health and well-being and sustainability with our continued focus on productivity and innovation and with future targeted investments, we believe our medium-term ,annual earnings trend growth rate will be in the high single-digit percentages from these $4 to $4.50 per share baseline. With that operator please open the line for questions.